European Markets Soar: A Closer Look at the Numbers

European markets are on a roll, hitting new highs. The Stoxx 600, DAX, and CAC 40 indexes have all seen significant gains. This year alone, the Stoxx 600 has climbed 14% higher. With just a week left, it's looking like it will be the third year in a row of growth. Investors are keeping a close eye on Novo Nordisk. The Danish company just got FDA approval for a new GLP-1 pill. This is a big deal because it gives Novo Nordisk a leg up on its U. S. competitor, Eli Lilly. As a result, Novo Nordisk's stock price jumped 7. 5%. Another European health company, Zealand Pharma, also saw its shares rise by 2. 3%. Meanwhile, French biotech firm Abivax had a good day too. Its shares went up 1. 4%, though this was a bit less than the 15. 4% gain it saw the day before.Not all news was good, though. Danish renewables giant Orsted took a hit, with its shares dropping 13%. This came after the U. S. Department of the Interior suspended leases on five offshore wind projects. Orsted had previously successfully challenged a similar stop-order earlier this year. In other news, Greenland's Prime Minister brushed off President Trump's appointment of a "special envoy" to the territory. Trump has been trying to buy Greenland, partly because of its rare earth minerals. Spain is set to release its final GDP data on Tuesday. Earlier data showed a year-on-year growth of 2. 8%. Across the globe, Asia-Pacific markets opened higher on Tuesday. This follows a boost from the AI trade on Wall Street overnight. In the U. S. , stock futures were trading near the flatline on Monday night after a strong start to the week.